Clinical Trial Update: A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a triple therapy of boceprevir, pegylated interferon alfa-2a (Pegasys) and ribavirin (Copegus) in previously untreated genot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)
• Victrelis (boceprevir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2015-08-07